In vivo myogenic potential of human CD133+ muscle-derived stem cells: A quantitative study

Molecular Therapy

Volumn 17, Issue 10, 2009, Pages 1771-1778

  Negroni, Elisa ^a,b,c   Riederer, Ingo ^a,b,c,d   Chaouch, Soraya ^a,b,c   Belicchi, Marzia ^e   Razini, Paola ^e   Di Santo, James ^f   Torrente, Yvan ^e   Butler Browne, Gillian S ^a,b,c   Mouly, Vincent ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b Sorbonne Université   (France)

^c CNRS   (France)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITY OF MILAN   (Italy)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; LAMIN A; LAMIN C; SPECTRIN; TRANSCRIPTION FACTOR PAX7;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE POTENTIAL; CELL MIGRATION; CELL RENEWAL; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; COLD INJURY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFANT; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SATELLITE CELL; STEM CELL TRANSPLANTATION; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; GLYCOPROTEINS; HUMANS; MICE; MICE, MUTANT STRAINS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; PEPTIDES; STEM CELLS;

EID: 70349880516     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.167     Document Type: Article

References (50)

1. Decary, S, Mouly, V, Hamida, CB, Sautet, A, Barbet, JP and Butler-Browne, GS (1997). Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum Gene Ther 8: 1429-1438.
2. Mauro, A (1961). Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9: 493-495.
3. Seale, P, Sabourin, LA, Girgis-Gabardo, A, Mansouri, A, Gruss, P and Rudnicki, MA (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786.
4. Irintchev, A, Zeschnigk, M, Starzinski-Powitz, A and Wernig, A (1994). Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev Dyn 199: 326-337.
5. Renault, V, Rolland, E, Thornell, LE, Mouly, V and Butler-Browne, G (2002). Distribution of satellite cells in the human vastus lateralis muscle during aging. Exp Gerontol 37: 1513-1514.
6. Beauchamp, JR, Heslop, L, Yu, DS, Tajbakhsh, S, Kelly, RG, Wernig, A et al. (2000). Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151: 1221-1234.
7. Zammit, PS, Partridge, TA and Yablonka-Reuveni, Z (2006). The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 54: 1177-1191.
8. Blau, HM, Webster, C and Pavlath, GK (1983). Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 80: 4856-4860.
9. Decary, S, Hamida, CB, Mouly, V, Barbet, JP, Hentati, F and Butler-Browne, GS (2000). Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 10: 113-120.
10. Wang, Z, Allen, JM, Riddell, SR, Gregorevic, P, Storb, R, Tapscott, SJ et al. (2007). Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum Gene Ther 18: 18-26.
11. Alter, J, Lou, F, Rabinowitz, A, Yin, H, Rosenfeld, J, Wilton, SD et al. (2006). Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 12: 175-177.
12. van Deutekom, JC, Janson, AA, Ginjaar, IB, Frankhuizen, WS, Aartsma-Rus, A, Bremmer-Bout, M et al. (2007). Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357: 2677-2686.
13. Goyenvalle, A, Vulin, A, Fougerousse, F, Leturcq, F, Kaplan, JC, Garcia, L et al. (2004). Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306: 1796-1799.
14. Skuk, D, Goulet, M, Roy, B, Chapdelaine, P, Bouchard, JP, Roy, R et al. (2006). Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 65: 371-386.
15. Torrente, Y, Belicchi, M, Sampaolesi, M, Pisati, F, Meregalli, M, D'Antona, G et al. (2004). Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114: 182-195.
16. Hollemann, D, Budka, H, Löscher, WN, Yanagida, G, Fischer, MB and Wanschitz, JV (2008). Endothelial and myogenic differentiation of hematopoietic progenitor cells in inflammatory myopathies. J Neuropathol Exp Neurol 67: 711-719.
17. Krause, DS, Fackler, MJ, Civin, CI and May, WS (1996). CD34: Structure, biology, and clinical utility. Blood 87: 1-13.
18. Silva-Barbosa, SD, Butler-Browne, GS, Di Santo, JP and Mouly, V (2005). Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation. Cell Transplant 14: 457-467.
19. Qu-Petersen, Z, Deasy, B, Jankowski, R, Ikezawa, M, Cummins, J, Pruchnic, R et al. (2002). Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 157: 851-864
20. Goodell, MA, Brose, K, Paradis, G, Conner, AS and Mulligan, RC (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
21. Gussoni, E, Soneoka, Y, Strickland, CD, Buzney, EA, Khan, MK, Flint, AF et al. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-394.
22. Asakura, A, Seale, P, Girgis-Gabardo, A and Rudnicki, MA (2002). Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159: 123-134.
23. + adult stem cells during muscle regeneration. Cell 113: 841-852.
24. Kuang, S, Chargé, SB, Seale, P, Huh, M and Rudnicki, MA (2006). Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 172: 103-113.
25. Tamaki, T, Akatsuka, A, Ando, K, Nakamura, Y, Matsuzawa, H, Hotta, T et al. (2002). Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157: 571-577.
26. Minasi, MG, Riminucci, M, De Angelis, L, Borello, U, Berarducci, B, Innocenzi, A et al. (2002). The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129 2773-2783.
27. Sampaolesi, M, Torrente, Y, Innocenzi, A, Tonlorenzi, R, D'Antona, G, Pellegrino, MA et al. (2003). Cell therapy of alpha-sarcoglycan null dystrophic mice through intraarterial delivery of mesoangioblasts. Science 301: 487-492.
28. Sampaolesi, M, Blot, S, D'Antona, G, Granger, N, Tonlorenzi, R, Innocenzi, A et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
29. Dellavalle, A, Sampaolesi, M, Tonlorenzi, R, Tagliafico, E, Sacchetti, B, Perani, L et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9: 255-267.
30. Crisan, M, Yap, S, Casteilla, L, Chen, CW, Corselli, M, Park, TS et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
31. Asahara, T, Murohara, T, Sullivan, A, Silver, M, van der Zee, R, Li, T et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
32. Herrera, MB, Bruno, S, Buttiglieri, S, Tetta, C, Gatti, S, Deregibus, MC et al. (2006). Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24: 2840-2850.
33. Reyes, M, Lund, T, Lenvik, T, Aguiar, D, Koodie, L and Verfaillie, CM (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625.
34. De Bari, C, Dell'Accio, F, Vandenabeele, F, Vermeesch, JR, Raymackers, JM and Luyten, FP (2003). Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160 909-918.
35. Dezawa, M, Ishikawa, H, Itokazu, Y, Yoshihara, T, Hoshino, M, Takeda, S et al. (2005). Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
36. Rodriguez, AM, Pisani, D, Dechesne, CA, Turc-Carel, C, Kurzenne, JY, Wdziekonski, B et al. (2005). Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201: 1397-1405.
37. Weigmann, A, Corbeil, D, Hellwig, A and Huttner, WB (1997). Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94: 12425-12430.
38. Miraglia, S, Godfrey, W, Yin, AH, Atkins, K, Warnke, R, Holden, JT et al. (1997). A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
39. Shmelkov, SV, St Clair, R, Lyden, D and Rafii, S (2005). AC133/CD133/ Prominin-1. Int J Biochem Cell Biol 37: 715-719.
40. Benchaouir, R, Meregalli, M, Farini, A, D'Antona, G, Belicchi, M, Goyenvalle, A et al. (2007). Restoration of human dystrophin following transplantation of exonskipping- engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1: 646-657.
41. Irintchev, A, Langer, M, Zweyer, M, Theisen, R and Wernig, A (1997). Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J Physiol (Lond) 500 (Pt 3): 775-785.
42. Cooper, RN, Thiesson, D, Furling, D, Di Santo, JP, Butler-Browne, GS and Mouly, V (2003). Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation. Hum Gene Ther 14: 1169-1179.
43. Sato, T, Laver, JH and Ogawa, M (1999). Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94: 2548-2554.
44. Mouly, V, Aamiri, A, Bigot, A, Cooper, RN, Di Donna, S, Furling, D et al. (2005). The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 184 3-15.
45. + stem cells in Duchenne muscle patients. Cell Transplant 16: 563-577.
46. Satoh, A, Huard, J, Labrecque, C and Tremblay, JP (1993). Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J Histochem Cytochem 41: 1579-1582.
47. Civin, CI, Strauss, LC, Brovall, C, Fackler, MJ, Schwartz, JF and Shaper, JH (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133: 157-165.
48. Zheng, B, Cao, B, Crisan, M, Sun, B, Li, G, Logar, A et al. (2007). Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25: 1025-1034.
49. Edom, F, Mouly, V, Barbet, JP, Fiszman, MY and Butler-Browne, GS (1994). Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains. Dev Biol 164: 219-229.
50. Di Donna, S, Mamchaoui, K, Cooper, RN, Seigneurin-Venin, S, Tremblay, J, Butler-Browne, GS et al. (2003). Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol Cancer Res 1: 643-653.